Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -347.91% is 103% below its 3-year average of -171.26%, around the middle of its 3-year range (-1047.11%–0.00%).
35.14% above its 12-month average of -536.43%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -412.68%.
OPERATING MARGIN
-347.91%
OPERATING MARGIN AVG TTM
-536.43%
OPERATING MARGIN AVG 3Y
-171.26%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+35.14%
CURRENT VS 3Y AVG
-103.14%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 782 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
DataMEDS AI, Inc.
Market Cap
$8.47M
Operating Margin
-347.91%
TTM Avg
-536.43%
3Y Avg
-171.26%
5Y Avg
N/A
Market Cap
$8.46M
Operating Margin
-70.47%
TTM Avg
-55.55%
3Y Avg
-42.46%
5Y Avg
-30.21%
Market Cap
$8.18M
Operating Margin
N/A
TTM Avg
-193400.24%
3Y Avg
-134850.20%
5Y Avg
-97032.76%
Market Cap
$8.06M
Operating Margin
0.00%
TTM Avg
-476.50%
3Y Avg
-901.45%
5Y Avg
-600.97%
Market Cap
$8.05M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$8.00M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.96M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.70M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$9.21M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DataMEDS AI, Inc. (MEDS) | $8.47M | -347.91% | -536.43% | -171.26% | N/A |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.46M | -70.47% | -55.55% | -42.46% | -30.21% |
| HeartSciences Inc. (HSCS)vs › | $8.18M | N/A | -193400.24% | -134850.20% | -97032.76% |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.06M | 0.00% | -476.50% | -901.45% | -600.97% |
| GT Biopharma, Inc. (GTBP)vs › | $8.05M | 0.00% | 0.00% | 0.00% | 0.00% |
| ENDRA Life Sciences Inc. (NDRA)vs › | $8.00M | 0.00% | 0.00% | 0.00% | 0.00% |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.96M | 0.00% | 0.00% | 0.00% | 0.00% |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.70M | 0.00% | 0.00% | 0.00% | 0.00% |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.33M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
-41.3%
Operating Margin
-347.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -412.68% |
| 2026-03-31 | -385.72% |
| 2025-12-31 | -766.04% |
| 2025-09-30 | -1047.11% |
| 2025-06-30 | -70.60% |
| 2025-03-31 | -288.57% |
| 2024-12-31 | -30.20% |
| 2024-09-30 | -30.75% |
| 2024-06-30 | -21.89% |
| 2024-03-31 | -18.71% |
| 2023-12-31 | -30.01% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
